FT商学院

Pandemic resilience effort must match Covid R&D funding, says health chief

Chair of 100 Days Mission warns of huge economic cost if world cannot respond swiftly to new pandemics

Governments and industry should invest as much on preparing for pandemics as they have on Covid-19 research to avoid costly lockdowns, the chair of a body aiming to boost preparations for future health crises has warned.

The G7-backed 100 Days Mission was set up in 2021 to focus efforts on producing tests, treatments and vaccines at scale within 100 days of a new pandemic being declared by the World Health Organization.

But four years after the outbreak of Covid-19, Mona Nemer, the chair of the mission’s steering group, said pandemic preparedness was being taken “for granted”. She urged countries and the pharmaceutical sector to boost funding to tackle nine other high-risk pathogens identified as threats by the WHO.

您已阅读22%(724字),剩余78%(2529字)包含更多重要信息,订阅以继续探索完整内容,并享受更多专属服务。
版权声明:本文版权归manbetx20客户端下载 所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。
设置字号×
最小
较小
默认
较大
最大
分享×